0000899243-20-021196.txt : 20200804 0000899243-20-021196.hdr.sgml : 20200804 20200804182236 ACCESSION NUMBER: 0000899243-20-021196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200731 FILED AS OF DATE: 20200804 DATE AS OF CHANGE: 20200804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nathan Daniel CENTRAL INDEX KEY: 0001777126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38977 FILM NUMBER: 201074694 MAIL ADDRESS: STREET 1: 432 PARK AVENUE SOUTH, 12TH FLOOR STREET 2: C/O PHREESIA, INC. CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phreesia, Inc. CENTRAL INDEX KEY: 0001412408 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 432 PARK AVENUE S. STREET 2: 12TH FLOOR CITY: New York STATE: NY ZIP: 10016 BUSINESS PHONE: 646-747-9959 MAIL ADDRESS: STREET 1: 432 PARK AVENUE S. STREET 2: 12TH FLOOR CITY: New York STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Phreesia Inc DATE OF NAME CHANGE: 20070914 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-31 0 0001412408 Phreesia, Inc. PHR 0001777126 Nathan Daniel C/O PHREESIA, INC. 432 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10016 0 1 0 0 Chief Technology Officer Common Stock 2020-07-31 4 M 0 7000 0.69 A 65196 D Common Stock 2020-07-31 4 S 0 8804 30.0308 D 56392 D Common Stock 7963 I By Spouse Stock Option (Right to Buy) 0.69 2020-07-31 4 M 0 7000 0.00 D 2022-06-18 Common Stock 7000 18030 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option is fully vested and exercisable as of the date hereof. /s/ Charles Kallenbach by Power of Attorney for Daniel Nathan 2020-08-03